Company Management
Johan Häggblad, PhD - Managing Director
Dr Häggblad has more than 25 years’ experience in the pharmaceutical industry served in managerial and executive roles at KaroBio AB (1989-1997), Pharmacia Corporation (1997-2001) and NeuroNova (2001-2007). He has a professional background in international pharma R&D as well as in business development and has a track record of several license, asset transfer and supply transactions. Dr Häggblad holds a BSc in Chemistry and a PhD in Neurochemistry and Neurotoxicology from Stockholm University. He received postdoctoral training in physiology and pharmacology at New York University and Oxford University, and in business and administration at Warwick University, UK.
Anders Hultman, BSc - Chief Financial Officer
Mr Hultman has more than 15 years’ experience in managerial and executive positions mainly in finance, sales and marketing. Furthermore, he has extensive international experience from several executive positions such as CFO, Sales Director, Product Marketing Director and CEO in the IT, Telecom and e-commerce industry. He has also worked as a journalist at Reuters and founded several companies. Mr Hultman received his BSc in Business Administration and Economics from Uppsala University.
Alex Mercer, PhD - Clinical Development Director
Dr Mercer joined Pharmalink in 2010 and has since successfully driven development strategies and clinical trials. Dr Mercer previously held management positions at NeuroNova AB (2000-2008) as Head of Discovery and directing the Early Clinical Development Division at TFS (2008-2010). He holds a PhD in Biochemistry from University College London and has over 10 years of post-doctoral experience in neurobiology gained at Uppsala University and as a scientist in industry.
Marek Poszepczynski, M Sci Eng - Business Development Director
Mr Poszepczynski has more than 15 years of international experience in the life science industry with a focus on licensing and financing. He held management positions at Handelsbanken (2010-2012) as lead equity analyst, VP Business Development at Karolinska Development AB (2008-2010) and Licensing Director at Biovitrum AB (2002-2008). In his role as business director, Mr Poszepczynski participated in two initial public offerings and a number of licensing and asset transfer transactions.
Sofia Rendón Rapp, M Sc Pharm - Pharmaceutical Development Director
Ms Rendón Rapp has extensive EU and US CMC and Quality Assurance experience and is currently responsible for the development and supply of drug product, and CMC/Quality documentation. Prior to joining Pharmalink in 2011, she was Regulatory Affairs Manager, CMC Specialist, at Oasmia Pharmaceutical (2008-2011) and before that she held a Pharmaceutical Assessor position at the Swedish Medical Products Agency (2002-2008).